We found that HNK induced GR translocation to the nucleus, MIG6 expression, and subsequent EGFR degradation, and we propose that this pathway is responsible for the ability of HNK to interfere with NASH-to-HCC progression (Figure 8). The gene discussed is NR3C1; the disease is metabolic dysfunction-associated steatohepatitis.